LifeVantage has outlined its capital expenditure for fiscal year 2027, projecting it to be between $3 million and $3.5 million. The company is withholding formal guidance at this time due to an ongoing CEO transition.
LifeVantage Projects FY 2027 Capex at $3M-$3.5M Amid CEO Transition
LifeVantageCapexCEO TransitionFinancial OutlookBiotech Stocks

